Conceptio › Archive › HAL (France)
HAL (France)open access

Glycemic and renal effects of SGLT2 Inhibitors in Prader-Willi syndrome: Benefits and risks

Juliette Jacquot-Thierry et al.
HAL (France) · Papers · License: Open Access
Open Source ↗
type-2-diabetes
0, Prader willi syndrom, Type 2 diabetes, SGLT2 inhibitor
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 268648
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.